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Objective: To study attitudes toward menopause in women with or at risk of human 
immunodeﬁ  ciency virus (HIV) aged 35 to 60 in New York City, NY, USA.
Design: Data were obtained at the baseline interview in a cohort study of menopause. Of 502 
participating women, 92 were postmenopausal and 162 were perimenopausal.
Results: Overall, 37.5% of women had a relatively favorable attitude toward menopause. African 
Americans had a 72% greater odds of a positive attitude (OR = 1.72, 95% CI 1.16–2.57) than 
all other groups after adjusting for covariates. Hispanic women had the least favorable view of 
menopause. Experience of 3 menopausal symptoms and negative life events—being a witness to 
a murder, and the death of a child—were signiﬁ  cantly associated with negative attitudes towards 
menopause (OR = 0.62, 95% CI 0.42–0.93 and OR = 0.64, 95% CI 0.43–0.93, respectively). 
Depressive symptoms, street drug use, and having a domestic partner, which is signiﬁ  cant in 
single variable analyses, did not remain independent predictors in multivariate results. HIV status, 
menopause status, and age at interview were not associated with menopause attitudes.
Conclusions: HIV-infected, drug-using, low-income women showed generally unfavorable 
attitudes towards menopause. High stress life events coupled with a high prevalence of depres-
sive symptoms indicate this population has special needs marked by the menopause transition 
into older age.
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Introduction
The menopause marks a major biological transition in the lives of all women with 
potentially deep psychological and socioeconomic changes (Avis and McKinlay 1991). 
Attitudinal aspects of the menopause transition have been studied for several decades 
starting with studies by Neugarten and colleagues (1963). However, most studies of 
mid-life and menopause attitudes have systematically excluded women with serious 
illness, disability, or substance abuse.
As the human immunodeﬁ  ciency virus (HIV) epidemic enters its third decade, 
a high percentage of women with HIV will also be entering menopause, their lives 
extended by improvements in antiretroviral therapies, ie, Highly Active Anti-Retroviral 
Therapy (HAART) (Palella et al 1998). Examination of the literature provides little 
insight into how women with HIV/acquired immunodeﬁ  ciency syndrome (AIDS) or 
who use street drugs for long periods may experience the menopause transition.
We assessed attitudes towards menopause in an impoverished, urban population 
of midlife women with and at-risk for HIV infection. We hypothesized that HIV and 
street drug use would be associated with a less positive attitude toward menopause 
than for the HIV-uninfected women in our study who did not use drugs. We felt it 
equally plausible that menopause was just one more, relatively minor stressor among 
the many difﬁ  cult circumstances among women with HIV as has been suggested by a 




As previously described (Schoenbaum et al 2005), a total of 
620 women participated in the “Natural History of Meno-
pause in HIV-Infected Women” (Ms Study). Overall enroll-
ment was guided to produce a study with balanced numbers 
of HIV-infected and uninfected women and with half of the 
women in the HIV-infected and uninfected groups having a 
history of heroin or cocaine use in the past ﬁ  ve years. This 
study utilizes data gathered during the enrollment phase 
with ascertainment of menopause status with 12 months of 
amenorrhea postbaseline for those in the menopausal transi-
tion at time of interview.
Deﬁ  nition of menopause, perimenopause, 
and menopausal symptoms
Natural menopause was deﬁ  ned according to the World 
Health Organization (WHO 1996) as at least 12 consecutive 
months of amenorrhea not due to surgery or other obvious 
cause, such as extreme weight loss. Perimenopause was 
deﬁ  ned as absence of menses in at least 3 cycles but no more 
than 11 during the past 12 months. For this analysis we did 
not distinguish between early and late perimenopause due 
to small numbers of women in the perimenopause. Meno-
pausal symptoms were classiﬁ  ed into six groups, vasomotor, 
genitourinary, musculoskeletal, weight gain, palpitations, and 
insomnia and excluded psychological symptoms which were 
ubiquitous in the population (Miller et al 2005).
Dependent variable
A modiﬁ  ed version of the Neugarten Attitudes Toward Meno-
pause (ATM), a 35-item questionnaire, was administered as 
part of the baseline Ms interview. For each item on the ATM, 
women were asked to indicate if they agreed strongly, agreed 
somewhat, disagreed somewhat, or disagreed strongly or 
could not agree or disagree (don’t know). Since the original 
Neugarten ATM was not designed for populations such as 
ours, a panel of 17 women familiar with the study popula-
tion (primarily experienced research interviewers) selected 
a subset of ATM items. A 65% agreement was required by 
the panel in order to include an item. The items intended for 
middle-class, married women in the 1960s were dropped 
as inappropriate to a sample with an extensive history of 
street drug use and who are largely without partners. For 
example, we dropped: “After menopause, a woman gets 
more interested in activities outside the home.” In the end 
we used 27 items (15 negative items, and 12 positive items) 
taken from the original ATM. Negative items were reverse 
coded for summation with positive items. Using this modiﬁ  ed 
questionnaire, we condensed scores to a simple agree, don’t 
know, or disagree code similar to scoring used for attitude 
items in the Study of Women Across the Nation (SWAN) 
(Sommer et al 1999). We examined variables in relation to 
average score and also to scores above 2, indicating more 
positive attitude, compared to those 2 and lower
Exclusions
Of the 620 women originally enrolled in Ms, women who had 
a hysterectomy and/or bi-lateral oophorectomy prior to enter-
ing the perimenopause (n = 22) were excluded. In addition, 
24 women taking hormones for the symptoms of menopause 
during perimenopause within 6 months of interview were also 
excluded due to an inability to properly classify their status. 
Fifty-six women responding “don’t know” more than 25% of 
the time on the ATM were dropped from analysis. Based on 
responses to questions on menopause symptoms, we found 
high nonresponse on the attitudes portion of the study instru-
ment was likely to indicate lack of interest rather than simple 
lack of knowledge. A further 16 participants were excluded 
for incomplete or missing data. After the above exclusions, 
502 women comprised the sample for this analysis.
Statistical methods
Bivariate analysis of baseline characteristics was performed 
using chi-square, Fishers’ exact test, ANOVA, Spearman 
correlation, or Wilcoxon rank tests as appropriate. Multiple 
logistic regression models were used to identify factors 
independently associated with an average score above 2 
compared with 2 or lower. Variables examined included age 
and age2, race/ethnicity, education, marital status, HIV status, 
CD4 + cell count, HAART treatment, drug and alcohol use, 
menopause status, menopause symptoms, parity, body mass 
index (BMI), negative life events, and depressive symptoms. 
Women were classed as having depressive symptoms if 
Center for Epidemiologic Studies Short Depression Scale 
(CES-D) scores 23 as we have done in previous studies 
(Moore et al 1999; Schoenbaum et al 2005). Data were ana-
lyzed using Stata 9.0 (College Station, TX).
Results
Among the 502 women, 260 (51.8%) were HIV-seropositive, 
and 92 women (18.3%) were postmenopausal. For HIV-
positive, median CD4 count was 455.5 cells/m3 with an 
interquartile range (IQR) of 274–682. Sixty-four percent 
(168/261) were maintained on HAART at that time. Clinical Interventions in Aging 2008:3(3) 563
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The median age at interview was 43 (IQR: 40–46) with 
27.3% reported using heroin and/or cocaine at the time of 
interview. The sample included 48.6% African American, 
40.2% Hispanic, 9% non-Hispanic white, and 2.2% “other”, 
which included mixed race.
The overall average attitude toward menopause score 
(scores from 1 most negative to 3 most positive) was 1.93 
with IQR of 1.77–2.10. Among 502 women, 37.5% (188/502) 
had an average score 2 showing a relatively favorable 
attitude toward menopause. We found no differences in 
attitude toward menopause by HIV infection status: 37.3% 
of the 260 HIV-seropositive women and 37.6% of the 242 
seronegative women had scores indicating a positive attitude 
toward menopause. There were no associations between CD4 
count or use of HAART with menopause attitude among 
those with HIV. African American women showed the most 
positive attitudes toward menopause compared with all other 
race or ethnic groups (Table 1). Women reporting a current 
domestic partner (married or common-law) were less likely 
to have a positive attitude toward menopause than those with 
no partner (32.1% vs. 41.3%, p = 0.035).
Reproductive and medical history
Menopause symptoms, but not menopause status, showed an 
inverse relationship with menopause attitude when women 
had more than 3 symptoms of any kind (p = 0.002) as shown 
in Table 1. Single menopause symptoms, such as hot ﬂ  ashes, 
were not associated with attitude score.
Depressive symptoms and negative 
life events
Depressive symptoms based on the CESD were related to a 
more negative menopause attitude score (p = 0.037). High 
rates of traumatic events were found among our participants: 
42% abused as children and 36.1% molested as children, 
45.8% raped and 59.4% assaulted as adults. In addition, 
26.7% witnessed murder and 19.6% suffered a child’s death. 
Witness to murder and death of a child showed a statistically 
signiﬁ  cant difference in menopause attitude (Table 1).
Drug and alcohol use
For women reporting current use of heroin and/or cocaine in any 
form or route within 6 months of baseline interview, a some-
what more positive view of menopause was shown compared 
with nonusers (43.8% vs. 35.1%, p = 0.072). There was a simi-
lar result for problem drinking based on the CAGE screening 
instrument. Enrollment in methadone and cigarette smoking 
were not associated with attitudes toward menopause.
Multivariate results
African Americans showed 72% greater odds of a positive 
attitude (ORadj = 1.72, 95% CI 1.16–2.57) than all other race 
or ethnic groups while adjusting for the other variables in this 
model (Table 2). Experience of 3 menopausal symptoms 
and negative life events—being a witness to a murder, and the 
death of a child—were signiﬁ  cantly associated with negative 
attitudes towards menopause (OR = 0.62, 95% CI 0.42–0.93 
and OR = 0.64, 95% CI 0.43–0.93, respectively). Depressive 
symptoms, street drug use, and having a domestic partner, 
which was signiﬁ  cant in single variable analyses, did not 
remain independent predictors in multivariate results. HIV 
status, menopause status, and age at interview were not asso-
ciated with menopause attitudes. Age, age2, and menopause 
status were examined in all models but dropped in the ﬁ  nal 
model due to consistent lack of association.
Discussion
The most prominent ﬁ  nding in our study is the overall low 
level of women expressing a positive attitude (37.5% posi-
tive, with 1.93 overall mean score) toward menopause in this 
impoverished population with a high prevalence of HIV. In 
contrast, the SWAN study (Sommer et al 1999) enrolled an 
ethnically diverse population and reported an overall mean 
“on the positive side of neutral.” A comparable result in our 
population would be an overall average above 2.00; in fact, it 
was infrequent to observe average scores above two on most 
subcategories of variables examined in our study as shown 
in Table 1. Similar to SWAN, Wilbur and colleagues (1995) 
showed an overall nonnegative, largely neutral attitude toward 
menopause in a small, random and diverse sample of women. 
Since these studies do not use identical menopause attitude 
items, we do not compare actual overall mean results.
Our study population differs from others as it has the 
lowest educational levels (43% not completing high school), 
severe stressors including homelessness, street drug use and 
addiction, and adverse life events such as witness to murder, 
sexual abuse and rape. These factors probably colored overall 
attitudes toward their lives in general.
Menopause status and symptoms
Contrary to studies showing postmenopausal status associated 
with positive attitudes toward menopause (Neugarten et al 
1963; Wilbur et al 1995; Sommer et al 1999), our postmeno-
pausal women did not demonstrate more positive attitudes 
than peri- or premenopausal women. However, having more 
than 3 symptoms of menopause was associated with more 
negative menopause attitude in our data, suggesting that Clinical Interventions in Aging 2008:3(3) 564
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Table 1 Single variable associations with attitudes toward menopause score* in (N = 502) women enrolled in Menopause Study (Ms)
    n (%)  Mean   % Positive   p-value*
     score  attitude
Age at baseline        0.757
 35–44  253  (50.4)  1.93  39.1
 45–49  179  (35.7)  1.89  34.6
 50–54  49  (9.8)  1.98  36.7
 55+ 21  (4.2)  2.00  42.9
Race/Ethnicity       0.002
 African  American  244  (48.6)  1.97  44.3 
 Hispanic  202  (40.2)  1.89  29.7
 White  45  (9.0)  1.91  37.8 
 Other  11  (2.2)  1.83  27.3 
Education (years)        0.498
  11 218  (43.4)  1.90  35.8 
 12+ 284  (56.6)  1.94  38.7 
Marital status        0.035
  Has partner  209 (41.6)  1.89  32.1
  No partner  293 (58.4)  1.95  41.3 
Menopause status        0.912
 Menopause  92  (18.3)  1.94  39.1 
 Perimenopause  162  (32.3)  1.93  36.4 
 Premenopause  248  (49.4)  1.91  37.5 
Menopause symptoms at baseline        0.002
  0–3 symptoms  311 (62.0)  1.95  42.8  0.332
  3 symptoms  191 (38.0)  1.89  28.8 
Parity (number of livebirths)       
 None  59  (11.8  )  1.92  39.0 
  1–2  201  (40.0)  1.96  41.8
  3–4  170  (33.9)  1.90  34.1 
  5   + 72  (14.3)  1.90  31.9 
Body mass index (BMI)        0.604
  18.5 (underweight)  7 (1.4)  2.01  57.1 
  18.5–24.9 (normal)  126 (25.1)  1.93  38.9 
  25–29.9 (overweight)  144 (28.7)  1.94  38.9 
  3 (obese)  224 (44.7)  1.91  35.3 
HIV infection status        0.945
 HIV-positive  260  (51.8)  1.93  37.3 
 HIV-negative  242  (48.2)  1.92  37.6 
CESD Score        0.037
  23 195  (38.8)  1.88  31.8 
  23 307  (61.2)  1.96  41.0 
Witness to murder        0.034
 Yes  134  (26.7)  1.88  30.0 
 No  368  (73.3)  1.94  40.2 
Abused as child        0.092
 Yes  211  (42.0)  1.90  33.2 
 No  291  (58.0)  1.96  40.6 
Molested as child        0.671
 Yes  181  (36.1)  1.92  38.7 
 No  321  (63.9)  1.93  36.8 
Raped as adult        0.730
 Yes  230  (45.8)  1.92  38.3 
 No  272  (54.2)  1.93  36.8 
Attacked as adult        0.940
 Yes  298  (59.4)  1.93  37.6 
 No  204  (40.6)  1.92  37.3 
Death of a child        0.035
 Yes  105  (20.9)  1.88  28.6 
 No  397  (79.1)  1.94  39.8 
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symptoms may outweigh menopause status. The SWAN study 
found physical symptoms associated with attitudes, however 
these symptoms were not independent of menopause status in 
multivariate models. The role of symptoms in menopause can 
be complex in our population. Many of our study participants 
experience a wide range of conditions such as tuberculosis, 
HIV-related symptoms, and drug withdrawal that can overlap 
or closely resemble some symptoms of menopause. In our 
investigation of this issue, we found that women did not 
mis-attribute menopause symptoms to other conditions so 
much as they simply did not associate them with menopause 
(Johnson et al 2008). For example, 70% attributed hot ﬂ  ashes 
to menopause and 29% attributed vaginal dryness to meno-
pause. Our study population also differs from others in its 
high prevalence of early menopause at a median age of 47 
(Schoenbaum et al 2005). The observed early menopause is 
supported in a subsample of the same Ms cohort members 
in which menopause symptoms are shown at younger ages 
than the general population (Miller et al 2005). Furthermore, 
analysis of reproductive hormone patterns in this population 
has shown that they are consistent with menopause status and 
support an earlier menopause onset (Santoro et al 2007). This 
study also conﬁ  rmed that age and WHO menopause status 
classiﬁ  cations used in our study were signiﬁ  cantly related to 
follicle stimulating hormone levels.
Demographic results
Consistent with other reports (Pham et al 1997; Sommer 
et al 1999), African American women had the most posi-
tive attitudes toward menopause: 44.3% positive compared 
with Hispanic women with 29.7% having a positive attitude. 
The literature shows less consistency for associations with 
educational attainment (McKinlay et al 1992), although the 
SWAN found higher education to be related to better atti-
tude after controlling on age, menopause status, and other 
variables. With over 43% of women not completing high 
school and the fairly uniform low socioeconomic status of 
our participants, we found no such association.
Having a domestic partner—especially a supportive 
partner—has been reported as a factor in a positive attitude 
towards menopause (Avis et al 2004). A supportive network 
has similarly been shown to relate to a positive attitude 
toward the menopausal transition (Rice 2005). Whether mar-
ried or common-law, having a domestic partner was related 
to less favorable attitudes toward menopause in our data but 
only in bivariate analyses.
Stressful life events, depressive symptoms, 
and HIV infection status
In our previous study (Miller et al 2005) we found that 
menopause symptoms were associated with depressive 
symptoms and negative life events; however, we did not 
Table 1 (Continued)
    n (%)  Mean   % Positive   p-value*
     score  attitude
Current drug user (cocaine/heroin)        0.072
 User  137  (27.3)  1.96  43.8
 Nonuser  365  (72.7)  1.91  35.1
Currently in methadone program        0.206
 Yes  175  (34.9)  1.90  33.7
 No  327  (65.1)  1.94  39.5
Problem drinking (any CAGE symptoms)        0.087
 Yes  269  (53.6)  1.94  40.9
 No  233  (46.4)  1.90  33.5
Current cigarette smoker        0.549
 Smoker  339  (67.5)  1.92  38.4
 Nonsmoker  163  (32.5)  1.93  35.6
Note: *Chi-squared.
Abbreviations: CES-D, Center for Epidemiologic Studies Short Depression Scale.
Table 2 Multiple logistic regression: Independent predictors of 
positive attitude toward menopause
Variable Adjusted  95%  conﬁ  dence   p-value
 odds  ratio  interval
Race/ethnicity    
 African  American  1.718  1.156–2.566  0.007
 White  1.353  0.685–2.670  0.384
 Hispanic      Reference
 Death  events*  0.635  0.432–0.933  0.021
 Menopause     
 Symptoms  3 0.622  0.418–0.925  0.019
Note: *Death of a child or witness to murder.Clinical Interventions in Aging 2008:3(3) 566
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ﬁ  nd depressive symptoms independently associated with 
menopause attitudes. Instead, in this study menopause 
symptoms and negative life events were related to attitude. 
The literature shows conﬂ  icting results on this issue with 
some reporting increases in depressive symptoms during the 
menopausal transition (Maartens et al 2002; Bromberger et al 
2003; Freeman et al 2004), while others do not (Woods and 
Mitchell 1997; Rabkin et al 1997; Avis et al 2001).
We found that HIV infection status per se was not associ-
ated with menopause attitudes. In other studies, the psycho-
logical proﬁ  le of impoverished women with HIV is more 
likely shaped by the milieu of poverty or drug problems than 
by HIV alone (Nyamathi 1992; Ward 1993). This appears to 
be the case for menopause as well.
Conclusions
For HIV-infected and drug-using women, the menopause 
transition is likely to be a very different experience than 
for women living in mainstream culture. Menopause is an 
important life event that can mark a change into a period of 
increasing health risk from cardiovascular disease, osteoporo-
sis, and early death. It is notable that these women who once 
thought they would die of HIV in a short period are now facing 
menopause amidst the burdens of poverty, multiple high stress 
events, and age-related chronic disease conditions.
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